Form 4: Amgen VP, Finance & CAO Matthew C. Busch Reports Changes in Beneficial Ownership
SEC Form 4
Matthew C. Busch, VP, Finance & CAO of Amgen Inc., reports a transaction involving common stock due to tax withholding on vesting Restricted Stock Units (RSUs).
Summary
- On April 30, 2024, Matthew C. Busch, VP, Finance & CAO of Amgen Inc., filed a Form 4 to report changes in beneficial ownership of Amgen's common stock.
- The transaction involved the disposition of 17 shares of common stock at a price of $276.38 per share.
- This disposition was related to the satisfaction of tax obligations upon the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Busch directly owns 4,653 shares of Amgen common stock, which includes vested and unvested RSUs and Dividend Equivalents (DEs).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and the transaction is related to tax obligations, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of transaction (disposal of shares for tax withholding). |
| 05/01/2024 | Date of Form 4 filing. |
| 05/05/2024 | Vesting date for 64 RSUs. |
| 04/30/2025 | Vesting date for 43 RSUs. |
| 11/05/2024 | Vesting date for 494 RSUs. |
| 11/05/2025 | Vesting date for 509 RSUs. |
| 05/02/2024 | Vesting date for 70 RSUs. |
| 05/02/2025 | Vesting date for 71 RSUs. |
| 05/02/2026 | Vesting date for 73 RSUs. |
| 05/02/2025 | Vesting date for 97 RSUs. |
| 05/02/2026 | Vesting date for 98 RSUs. |
| 05/02/2027 | Vesting date for 101 RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.